Cargando…

Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention

BACKGROUND: Coronary heart disease (CHD) is caused by the blockage or spasm of coronary arteries. Evidence shows that liver disease is related to CHD. However, the correlation between the Model for End-Stage Liver Disease (MELD) score and outcomes in patients after percutaneous coronary intervention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, You, Han, Min, Zheng, Ying-Ying, Zhu, Feng, Aisan, Aikebai, Maheshati, Tunike, Ma, Yi-Tong, Xie, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075702/ https://www.ncbi.nlm.nih.gov/pubmed/33959395 http://dx.doi.org/10.1155/2021/6401092

Ejemplares similares

Predictive value of combining leucocyte and platelet counts for mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention treatment in Chinese population: a retrospective cohort study
por: Yuan, Teng, et al.
Publicado: (2023)

The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention
por: Zhang, Da-Peng, et al.
Publicado: (2020)

ADS Score as a Novel Predictor of Outcomes in Patients Who Underwent Percutaneous Coronary Intervention
por: Zhang, Wen-Jing, et al.
Publicado: (2021)

Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI
por: Wang, Kai-Yang, et al.
Publicado: (2022)

Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Zhang, Jian, et al.
Publicado: (2021)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Impact of diabetes on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention
por: Ye, Zhen, et al.
Publicado: (2022)

Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention
por: Kırıs, Tuncay, et al.
Publicado: (2018)

Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" – Not "end-stage" after all
por: Jax, Thomas W, et al.
Publicado: (2009)

The Effect of Insulin Resistance on Prognosis of Non-Diabetic Patients Who Underwent Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2006)

From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease
por: Remillard, Taylor C., et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
por: Hua, Can, et al.
Publicado: (2022)

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention
por: Wang, Yong, et al.
Publicado: (2020)

Risk Factors for No-Reflow in Patients with ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Case-Control Study
por: Yu, Ying, et al.
Publicado: (2022)

Comparison of the prognostic value of SYNTAX score and clinical SYNTAX score on outcomes of Chinese patients underwent percutaneous coronary intervention
por: Li, Xiao-Qin, et al.
Publicado: (2021)

One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease
por: Lu, Daniel Y, et al.
Publicado: (2020)

Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention
por: Visternichan, Olga, et al.
Publicado: (2019)

Clinical Outcomes of patients with coronary artery disease who underwent FFR evaluation of intermediate coronary lesionS– COFFRS study
por: Prasad, Srinivasa, et al.
Publicado: (2017)

Outcomes of critically ill end-stage kidney disease patients who underwent major surgery
por: Petchmak, Peerawitch, et al.
Publicado: (2021)

Relationship between the ST-Segment Resolution and Microvascular Dysfunction in Patients Who Underwent Primary Percutaneous Coronary Intervention
por: Kim, Byung Gyu, et al.
Publicado: (2019)

Relationship between High Level of Estimated Glomerular Filtration Rate and Contrast-Induced Acute Kidney Injury in Patients who Underwent an Emergency Percutaneous Coronary Intervention
por: Yuan, Ying, et al.
Publicado: (2018)

Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data
por: Liu, Ru, et al.
Publicado: (2019)

All-Cause Mortality and Progression to End-Stage Kidney Disease Following Percutaneous Revascularization or Surgical Coronary Revascularization in Patients with CKD
por: Charytan, David M., et al.
Publicado: (2021)

In-Hospital Outcomes of Patients With Non-Alcoholic Fatty Liver Disease Who Underwent Percutaneous Coronary Intervention: A Nationwide Inpatient Sample Analysis
por: Ali, Hasan, et al.
Publicado: (2021)

Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis
por: Nerkiz, Polat, et al.
Publicado: (2015)

Is trans-radial approach related to an increased risk of radiation exposure in patients who underwent diagnostic coronary angiography or percutaneous coronary intervention? (The SAKARYA study)
por: Üreyen, Çağın Mustafa, et al.
Publicado: (2019)

How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?
por: Cui, Kongyong, et al.
Publicado: (2022)

Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis
por: Wu, Yihua, et al.
Publicado: (2011)

Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study
por: Ha, Sang Jin, et al.
Publicado: (2023)

Comparison of TIMI and Gensini score in patients admitted to the emergency department with chest pain, who underwent coronary angiography
por: İşcanlı, Murat Doğan, et al.
Publicado: (2014)

Challenging two-staged percutaneous coronary intervention in multivessel coronary artery disease with a high SYNTAX score: feasible, yet complicated
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

The Association of Socioeconomic Status with Three-Year Clinical Outcomes in Patients with Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention
por: Kim, Jeong Hun, et al.
Publicado: (2014)

Cardiac rehabilitation in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction: determinants of programme participation and completion
por: Sunamura, M., et al.
Publicado: (2017)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
por: Claassens, Daniel MF, et al.
Publicado: (2020)

Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention
por: Liu, Yupeng, et al.
Publicado: (2021)

Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention
por: Islam, Md Rabiul, et al.
Publicado: (2021)

Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Klancik, Viktor, et al.
Publicado: (2022)

Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Jalalian, Rozita, et al.
Publicado: (2023)

HEART and TIMI Scores Predict Severe Coronary Atherosclerosis in Patients With End-Stage Renal Disease
por: Parikh, Trishna B, et al.
Publicado: (2023)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i3303f7hf2fguhvgj3mcj6rfk0